Halozyme Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
CEOHelen I. Torley
CEOHelen I. Torley
Employees350
Employees350
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1998
Founded1998
Employees350
Employees350
HALO Key Statistics
Market cap7.21B
Market cap7.21B
Price-Earnings ratio17.02
Price-Earnings ratio17.02
Dividend yield—
Dividend yield—
Average volume1.62M
Average volume1.62M
High today$59.23
High today$59.23
Low today$57.66
Low today$57.66
Open price$58.80
Open price$58.80
Volume1.44M
Volume1.44M
52 Week high$66.00
52 Week high$66.00
52 Week low$37.97
52 Week low$37.97
HALO News
Simply Wall St 4d
Halozyme Therapeutics Has A Rock Solid Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that debt - which is usually involved in bankrupt...
Analyst ratings
56%
of 9 ratingsBuy
55.6%
Hold
44.4%
Sell
0%